BioTransplant (BT) acquired Eligix, a developer of therapy for patients receiving bone marrow (or stem cell) transplants and related procedures to treat leukemia, lymphoma, and other diseases,
BioTransplant Frequently Asked Questions (FAQ)
Where is BioTransplant's headquarters?
BioTransplant's headquarters is located at 101 Washington Street Suite 101 Foxborough, MA 02035, Foxborough.
What is BioTransplant's latest funding round?
BioTransplant's latest funding round is Series D.
How much did BioTransplant raise?
BioTransplant raised a total of $2.36M.
Who are the investors of BioTransplant?
Investors of BioTransplant include Rho Ventures.